212 related articles for article (PubMed ID: 10170246)
1. Cut pharmaceutical costs, but mind the legal dangers.
Abood RR
Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
[No Abstract] [Full Text] [Related]
2. Employers push to manage prescription drug costs.
Frieden J
Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
[No Abstract] [Full Text] [Related]
3. Liability relating to formularies and drug utilization management.
Elden DL
AAPPO J; 1991; 1(2):33-7, 43-6. PubMed ID: 10148900
[No Abstract] [Full Text] [Related]
4. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
5. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical risk sharing may cut losses, but is unlikely to produce gain.
Exec Solut Healthc Manag; 1998 Oct; 1(8):8-10. PubMed ID: 10186111
[No Abstract] [Full Text] [Related]
7. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
8. Controlling the cost of branded drugs.
Mandelker J
Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals: pharmaceutical cost controls.
Seay M; Lee LL
Issue Brief Health Policy Track Serv; 2007 Jan; ():1-22. PubMed ID: 17357250
[No Abstract] [Full Text] [Related]
10. Considerations in pharmaceutical conversion: focus on antihistamines.
Garbus SB; Moulton BW; Meltzer EO; Reich PR; Weinreb LF; Friedman JA; Orland BI
Am J Manag Care; 1997 Apr; 3(4):617-30. PubMed ID: 10169530
[TBL] [Abstract][Full Text] [Related]
11. Why do FEHBP and big unions excel at managing drug costs?
Berberabe T
Manag Care; 2003 Dec; 12(12):36-9. PubMed ID: 14723101
[No Abstract] [Full Text] [Related]
12. Expanding formulary and drug-use review programs.
Cheung MO
J Health Care Benefits; 1993; 3(1):33-6. PubMed ID: 10130346
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
MacEachern L
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
[TBL] [Abstract][Full Text] [Related]
14. Managing drug costs: the perception of managed care pharmacy directors.
Litton LM; Sisk FA; Akins ME
Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
[TBL] [Abstract][Full Text] [Related]
15. Liability implications of utilization review as a cost containment mechanism.
Schessler CE
J Contemp Health Law Policy; 1992; 8():379-406. PubMed ID: 10118988
[No Abstract] [Full Text] [Related]
16. Legislative challenges facing managed care pharmacy.
Epstein L
Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
[No Abstract] [Full Text] [Related]
17. Utilization of generics: a managed care failure?
Epstein D
Manag Care; 1997 May; 6(5):85-7. PubMed ID: 10168639
[No Abstract] [Full Text] [Related]
18. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
19. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
[No Abstract] [Full Text] [Related]
20. Managed care and the provision of hospice care.
Becker S; Pristave RJ
Manag Care Q; 1995; 3(1):39-43. PubMed ID: 10140986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
